This is a proposed Sole Source acquisition with Abbott Vascular, located in Santa Clara, California for XIENCE V Everolimus Eluting Coronary Stents for Keesler Air Force Base, MS. The anticipated date the solicitation will be posted to FedBizzOpps http://www.fedbizopps.gov is 7 April 2009. The applicable NAICS code for this acquisition is 339113 and the small business standard is 500 employees. The government anticipates award of a firm-fixed price contract as result of the solicitation. The solicitation must be downloaded from FedBizOpps, since copies of the solicitation will not be available for mailing. All prospective offerors must be registered in Central Contractor Registry (CCR) prior to award of contract with any DoD agency. Registration may be accomplished at http://www.ccr.gov. See Numbered Note 22.

Bid Protests Not Available